Cortagen
- Category
- Brain & Cognition
- Administration routes
- Injectable
- Regulatory status
- Not FDA-approved
What it is
Cortagen is a tetrapeptide bioregulator marketed for brain aging, cognitive support, and nerve repair. The case rests on animal and mechanistic work, reduced neurological deficit and faster nerve regeneration in preclinical models, while cognitive benefit and gene reactivation in humans are speculative. There is no controlled human safety data, and it is contraindicated in pregnancy. Supply is unregulated research-grade product; not FDA-approved.
Read Full recordStudied uses & evidence
Studied uses(6)
Neuroprotection — reduces neurological deficit and supports brain tissue recovery after ischemic injury in animal models
LowSingle rat study found faster ischemic recovery and reduced oxidative stress, not independently replicated.
Peripheral nerve regeneration — significantly enhances nerve fiber growth rate (+27%) and conduction velocity (+40%) post-injury
LowRat studies show faster nerve fiber growth and conduction recovery, but no controlled human trials exist.
Epigenetic rejuvenation — induces deheterochromatinization of aged chromatin, potentially reactivating age-silenced genes
LowHuman leukocyte studies show chromatin decondensation with age, but no clinical rejuvenation outcome demonstrated.
Evidence limits
PRECLINICAL ONLY — No FDA-approved human clinical trials exist for Cortagen. The evidence base is limited to: (1) In vivo animal studies in rats and mice demonstrating nerve regeneration, neuroprotection from ischemia, gene expression modulation, and behavioral recovery. (2) In vitro/ex vivo studies on chromatin remodeling and epigenetic regulation. (3) Limited human observational reports from Russian clinical practice noting "pronounced therapeutic effects" on posttraumatic peripheral nerve recovery and cardiovascular/cerebrovascular parameters, but these lack the rigor of double-blind placebo-controlled trials. The overall evidence level is LOW by Western clinical standards. Published research includes Russian institutions, a Georgian chromatin study, and Italian–Russian collaboration. Independent replication by Western research groups is absent.
Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)
Cautions & risk summary
General cautions
Pregnancy or breastfeeding
AbsoluteNo human reproductive safety data exists for this peptide. Effects on fetal development are unknown.
Children under 18
AbsoluteNo pediatric safety data. Not recommended for use in minors.
Known hypersensitivity
AbsoluteDiscontinue immediately if allergic reaction occurs (rash, swelling, difficulty breathing).
Risk summary(8)
Risks = level of concern: High · Moderate · Low · Theoretical
No human safety data from controlled clinical trials — risk profile is not well characterized
HighMild injection-site reactions (redness, swelling) reported anecdotally
LowContraindicated in pregnancy and breastfeeding due to lack of safety data
HighPatients with severe liver or kidney dysfunction should exercise caution as peptide metabolism/clearance may be altered
LowPotential for hypersensitivity or allergic reactions in susceptible individuals
LowQuality control concerns — as an unregulated research chemical, purity and composition may vary among unregulated products sold online
HighLong-term effects unknown; no chronic toxicity studies published
HighEpigenetic gene expression changes could theoretically have unpredictable downstream effects, though none have been documented
Theoretical
Further reading
- Overview in Full record
- Safety & interactions in Full record
- Research & benefits in Full record
- Regulation & availability in Full record
- Sources in Full record
- Frequently asked questions in Full record
This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer
Compiled from published research indexed through March 2026.